Enter assignee name

% Expired Patents = 33.3

Forward Citations = 176

Loading Chart...

5 inventors (with patents filed for the assignee):

John P Fruehauf (9 out of 11 patents)

Eugene Mechetner (4 out of 9 patents)

Larry Mark Weisenthal (2 out of 5 patents)

4. Ricardo J Parker (2 out of 2 patents)

5. Levy Kopelovich (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 7323300 - Methods for cancer prognosis and diagnosis (2008-01-29),

2. 7282346 - Methods for cancer prognosis and diagnosis (2007-10-16),

3. 7144704 - Methods and reagents for preparing and using immunological agents specific for P-glycoprotein (2006-12-05),

4. 6998234 - Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells (2006-02-14),

5. 6511806 - Methods for cancer prognosis and diagnosis (2003-01-28),

6. 6303324 - Methods for cancer prognosis and diagnosis (2001-10-16),

7. 6261795 - Radiation resistance assay for predicting treatment response and clinical outcome (2001-07-17),

8. 6008007 - Radiation resistance assay for predicting treatment response and (1999-12-28),

9. 5840507 - Methods for cancer prognosis and diagnosis (1998-11-24),

10. 5149527 - Immunopotentiating protocol for chemotherapy-responsive tumors (1992-09-22),

11. 4996145 - Method for detecting immune-mediated cytotoxicity (1991-02-26),

12. 4735895 - Cancer susceptibility test (1988-04-05),

Oncotech, Inc. is a leading biotechnology company specializing in developing innovative cancer diagnostics and personalized treatments. With a focus on precision medicine, Oncotech leverages cutting-edge technologies to provide clinically validated solutions for oncologists and their patients. Founded in 1993, the company has a strong track record of delivering reliable and actionable insights to improve cancer patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

12 Patents

#13 in Tustin, CA

#6,055 in California

#25,526 in US

#48,090 in the World

Tustin, CA, United States of America

Oncotech, Inc.